| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avalo Therapeutics, Inc. (AVTX) has 9 insiders with recent SEC Form 4 filings, including 29 buys and 0 sells. AVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 275.0K | $4.04M | - | |
| Other | 47.8K | $702.7K | -679 | |
| CFO | 19.1K | $281.0K | - | |
| Other | 3.6K | $53.4K | - | |
| Dir | 3.2K | $46.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2019 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 100,000 | $3.33 | $332,581.94 | +10.4% | |
| Jun 10, 2019 | Phillips Matthew V | Chief Commercial Officer | Buy | 523 | $2.85 | $1,489.24 | +105.2% | |
| Jun 10, 2019 | Miller Joseph M50 | Chief Financial Officer | Buy | 1,179 | $2.85 | $3,357.20 | +2.6% | |
| Jun 10, 2019 | Harrell James Archie Jr | Exec. VP, Mktg &External Comm | Buy | 4,398 | $2.85 | $12,523.31 | +105.8% | |
| Jun 10, 2019 | Calias Pericles | Chief Scientific Officer | Buy | 4,549 | $2.85 | $12,953.28 | +10.1% | |
| Jun 7, 2019 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 10,000 | $4.88 | $48,750.00 | +1.7% | |
| Jun 5, 2019 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 15,000 | $4.81 | $72,150.00 | - | |
| May 31, 2019 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 51,000 | $4.71 | $240,176.00 | - | |
| May 28, 2019 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 29,000 | $5.02 | $145,539.00 | - | |
| May 17, 2019 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 10,000 | $5.18 | $51,823.64 | - |